<SEC-DOCUMENT>0001437749-19-007857-index.html : 20190424
<SEC-HEADER>0001437749-19-007857.hdr.sgml : 20190424
<ACCEPTANCE-DATETIME>20190424162820
ACCESSION NUMBER:		0001437749-19-007857
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20190424
DATE AS OF CHANGE:		20190424
EFFECTIVENESS DATE:		20190424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-231013
		FILM NUMBER:		19764171

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>vxrt20190423_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: vxrt20190423_s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_141529.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: ex_141529.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ex_141530.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
Document 3 - file: ex_141530.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a1.jpg
<TEXT>
Document 4 - file: a1.jpg

</DOCUMENT>
</SEC-DOCUMENT>